These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2471007)
1. Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug. Bass AS; Murphy MB; Kohli JD; Goldberg LI J Cardiovasc Pharmacol; 1989 Apr; 13(4):667-71. PubMed ID: 2471007 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. Bass AS; Kohli JD; Lubbers N; Goldberg LI J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876 [TBL] [Abstract][Full Text] [Related]
3. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride. Goldberg LI; Bass AS Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837 [TBL] [Abstract][Full Text] [Related]
4. [Dopexamine: a new dopaminergic agonist]. Perrin G; Papazian L; Martin C Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685 [TBL] [Abstract][Full Text] [Related]
5. Inotropic mechanisms of dopexamine hydrochloride in horses. Muir WW Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs. Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543 [TBL] [Abstract][Full Text] [Related]
7. Temporal effects of an infusion of dopexamine hydrochloride in horses anesthetized with halothane. Young LE; Blissitt KJ; Clutton RE; Molony V Am J Vet Res; 1997 May; 58(5):516-23. PubMed ID: 9140561 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs. Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154 [TBL] [Abstract][Full Text] [Related]
9. Facilitation of adrenergic transmission in the canine heart by intracoronary infusion of angiotensin II: effect of prostaglandin synthesis inhibition. Lanier SM; Malik KU J Pharmacol Exp Ther; 1983 Dec; 227(3):676-82. PubMed ID: 6317843 [TBL] [Abstract][Full Text] [Related]
10. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats. Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses. Muir WW Equine Vet J Suppl; 1992 Feb; (11):24-9. PubMed ID: 9109955 [TBL] [Abstract][Full Text] [Related]
12. Presynaptic effects of dopexamine hydrochloride in the canine kidney. Bass AS Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154 [TBL] [Abstract][Full Text] [Related]
13. The effects of dopexamine on the cardiovascular system of the dog. Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482 [TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Port JD; Gilbert EM; Larrabee P; Mealey P; Volkman K; Ginsburg R; Hershberger RE; Murray J; Bristow MR Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367 [TBL] [Abstract][Full Text] [Related]
15. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors. Yorikane R; Kanda A; Kimura T; Satoh S J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122 [TBL] [Abstract][Full Text] [Related]
16. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs. Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210 [TBL] [Abstract][Full Text] [Related]
17. Metabolic and calorigenic effects of dopexamine in healthy volunteers. Geisser W; Träger K; Hähn A; Georgieff M; Ensinger H Crit Care Med; 1997 Aug; 25(8):1332-7. PubMed ID: 9267946 [TBL] [Abstract][Full Text] [Related]
18. Influence of 5-hydroxytryptamine on the pressor responses induced by norepinephrine and electrical sympathetic stimulation in the pithed rat. Terrón JA; Sánchez-López A; Ramírez-San Juan E; Castillo C; Villalón CM Arch Med Res; 1996; 27(3):291-7. PubMed ID: 8854384 [TBL] [Abstract][Full Text] [Related]
19. Enhancement by yohimbine of nicotine- and dimethylphenylpiperadinium-induced release of norepinephrine from cardiac sympathetic nerves of the dog: interaction of presynaptic alpha and nicotinic receptors. Kanda A; Koyanagawa H; Yorikane R; Kimura T; Satoh S J Pharmacol Exp Ther; 1987 Dec; 243(3):1095-100. PubMed ID: 2826754 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study. Gollub SB; Elkayam U; Young JB; Miller LW; Haffey KA J Am Coll Cardiol; 1991 Aug; 18(2):383-90. PubMed ID: 1677368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]